Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ADGRV1 DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1 ENSG00000164199 Adhesion G protein-coupled receptor V1 5 90529344-91164221 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067503 Approved Group enriched 6 adrenal gland: 56.5;cerebral cortex: 29.1 thyroid gland: 6.6 ANKH ANK, CCAL2, CMDJ, CPPDD, HANK ENSG00000154122 ANKH inorganic pyrophosphate transport regulator 5 14704804-14871778 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA068104 Approved Cytosol Expressed in all prostate: 49.5 CLCN1 ClC-1, CLC1 ENSG00000188037 Chloride channel, voltage-sensitive 1 7 143316126-143352083 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 17 skeletal muscle: 22.9 testis: 1.3 CLCN2 ClC-2, CLC2, EJM6 ENSG00000114859 Chloride channel, voltage-sensitive 2 3 184346185-184361651 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009397, HPA014545, HPA024108 Approved Approved Cytosol Mixed testis: 22.0 CLCN4 ClC-4, CLC4 ENSG00000073464 Chloride channel, voltage-sensitive 4 X 10156945-10237660 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031313, HPA063637 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 49.2;epididymis: 27.6 skeletal muscle: 14.6 CLCN7 CLC-7, CLC7, OPTA2, PPP1R63 ENSG00000103249 Chloride channel, voltage-sensitive 7 16 1444934-1475580 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043019, HPA043586 Supported Supported Nucleoplasm Expressed in all parathyroid gland: 40.4 CTNS CTNS-LSB, PQLC4 ENSG00000040531 Cystinosin, lysosomal cystine transporter 17 3636468-3661542 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046947 Supported Vesicles
Intermediate filaments Expressed in all testis: 43.3 DIRC2 FLJ14784, RCC4 ENSG00000138463 Disrupted in renal carcinoma 2 3 122794795-122881139 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA072579 Supported Vesicles Expressed in all parathyroid gland: 15.9 EI24 EPG4, PIG8, TP53I8 ENSG00000149547 Etoposide induced 2.4 11 125569216-125584687 Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047165, HPA051029 Uncertain Supported Endoplasmic reticulum
Golgi apparatus
Cytosol Tissue enriched 9 parathyroid gland: 1098.6 liver: 124.7 FLVCR1 AXPC1, FLVCR, MFSD7B, PCA ENSG00000162769 Feline leukemia virus subgroup C cellular receptor 1 1 212858255-212899363 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046646 Approved Approved Cell Junctions Tissue enhanced 0 small intestine: 21.9 duodenum: 10.0 FLVCR2 C14orf58, FLJ20371, MFSD7C ENSG00000119686 Feline leukemia virus subgroup C cellular receptor family, member 2 14 75578617-75663214 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037984 Supported Tissue enhanced 0 testis: 38.5 small intestine: 27.4 HIATL1 FLJ14753 ENSG00000148110 Hippocampus abundant transcript-like 1 9 94374551-94461042 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA017978 Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 251.1 HMGCR ENSG00000113161 3-hydroxy-3-methylglutaryl-CoA reductase 5 75336329-75362104 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008338, CAB016797 Approved Expressed in all cerebral cortex: 87.8 LAPTM4B LC27 ENSG00000104341 Lysosomal protein transmembrane 4 beta 8 97775057-97853013 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB020782, HPA068830 Uncertain Approved Golgi apparatus Expressed in all heart muscle: 134.9 LAPTM5 ENSG00000162511 Lysosomal protein transmembrane 5 1 30732469-30757820 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051293 Approved Approved Cytosol Expressed in all bone marrow: 801.2 LETM1 ENSG00000168924 Leucine zipper-EF-hand containing transmembrane protein 1 4 1811479-1856247 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011029, HPA011100 Supported Validated Mitochondria Expressed in all cerebral cortex: 16.3 MFSD2A FLJ14490, MFSD2 ENSG00000168389 Major facilitator superfamily domain containing 2A 1 39955112-39969968 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043107 Uncertain Approved Plasma membrane
Cytosol
Cytoplasmic bodies Tissue enhanced 0 epididymis: 114.6;seminal vesicle: 109.6 testis: 63.3 MFSD6L FLJ35773 ENSG00000185156 Major facilitator superfamily domain containing 6-like 17 8797162-8799349 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA023164 Uncertain Tissue enhanced 0 testis: 29.7 parathyroid gland: 8.3 MFSD8 CLN7, MGC33302 ENSG00000164073 Major facilitator superfamily domain containing 8 4 127917805-127965995 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044802 Approved Supported Nucleoplasm
Vesicles Expressed in all parathyroid gland: 12.2 MPC1 BRP44L, CGI-129, dJ68L15.3 ENSG00000060762 Mitochondrial pyruvate carrier 1 6 166364919-166383013 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045119, HPA055790 Supported Validated Mitochondria Expressed in all heart muscle: 409.2 MPC2 BRP44, DKFZP564B167 ENSG00000143158 Mitochondrial pyruvate carrier 2 1 167916729-167937040 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056091 Uncertain Expressed in all testis: 353.7 MTCH1 CGI-64, PSAP, SLC25A49 ENSG00000137409 Mitochondrial carrier 1 6 36968141-36986298 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015971 Approved Expressed in all thyroid gland: 568.7 MTCH2 SLC25A50 ENSG00000109919 Mitochondrial carrier 2 11 47617315-47642623 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038390 Approved Supported Mitochondria Expressed in all testis: 137.7 NIPA1 MGC35570, SPG6 ENSG00000170113 Non imprinted in Prader-Willi/Angelman syndrome 1 15 22773063-22829791 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023269 Uncertain Tissue enhanced 0 cerebral cortex: 38.3 parathyroid gland: 16.6 NIPA2 ENSG00000140157 Non imprinted in Prader-Willi/Angelman syndrome 2 15 22838641-22868384 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA067160, HPA071342 Approved Approved Golgi apparatus Expressed in all appendix: 45.7 NIPAL3 DJ462O23.2, NPAL3 ENSG00000001461 NIPA-like domain containing 3 1 24415794-24472976 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039978 Approved Approved Nucleoplasm Expressed in all prostate: 94.7 NIPAL4 ICHYN ENSG00000172548 NIPA-like domain containing 4 5 157460019-157474717 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038259 Approved Tissue enhanced 0 skin: 42.0 esophagus: 10.2 NPC1 ENSG00000141458 Niemann-Pick disease, type C1 18 23506184-23586898 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026618, CAB070132 Approved Expressed in all parathyroid gland: 110.9 NPC2 EDDM1, HE1, NP-C2 ENSG00000119655 Niemann-Pick disease, type C2 14 74476192-74494177 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000835 Supported Tissue enriched 19 epididymis: 16057.0 lung: 850.5 OCA2 BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P ENSG00000104044 Oculocutaneous albinism II 15 27754875-28099358 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 skin: 7.5;thyroid gland: 5.8 testis: 2.5 OSBPL5 KIAA1534, ORP5 ENSG00000021762 Oxysterol binding protein-like 5 11 3087116-3166739 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038335, HPA038712, HPA058727 Approved Validated Vesicles Mixed spleen: 20.1 OSBPL8 MST120, MSTP120, ORP8, OSBP10 ENSG00000091039 Oxysterol binding protein-like 8 12 76351797-76559809 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001309 Uncertain Approved Vesicles
Cytosol Expressed in all cerebral cortex: 39.6 OXA1L MGC133129, OXA1 ENSG00000155463 Oxidase (cytochrome c) assembly 1-like 14 22766522-22773041 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003531 Approved Supported Mitochondria Expressed in all parathyroid gland: 139.8 PQLC2 FLJ20320 ENSG00000040487 PQ loop repeat containing 2 1 19312326-19329300 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA057810 Approved Validated Vesicles Expressed in all testis: 16.3 RFT1 CDG1N ENSG00000163933 RFT1 homolog 3 53088483-53130462 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060327 Approved Vesicles Expressed in all testis: 25.8 SFXN4 ENSG00000183605 Sideroflexin 4 10 119140767-119165667 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018028, HPA020872 Approved Supported Vesicles Expressed in all thyroid gland: 47.1 SLC10A1 NTCP ENSG00000100652 Solute carrier family 10 (sodium/bile acid cotransporter), member 1 14 69775417-69797289 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042727 Approved Tissue enriched 392 liver: 212.1 gallbladder: 0.5 SLC10A2 ASBT, ISBT ENSG00000125255 Solute carrier family 10 (sodium/bile acid cotransporter), member 2 13 103043998-103066846 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA004795 Approved Group enriched 32 duodenum: 21.6;kidney: 15.3;small intestine: 52.2 gallbladder: 0.9 SLC10A3 DXS253E, P3 ENSG00000126903 Solute carrier family 10, member 3 X 154487306-154490690 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA021656 Approved Approved Intermediate filaments Expressed in all gallbladder: 33.2 SLC10A4 MGC29802 ENSG00000145248 Solute carrier family 10, member 4 4 48483343-48489196 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028835 Uncertain Supported Tissue enhanced 0 adrenal gland: 6.2;cerebral cortex: 4.0 cervix: 1.5 SLC10A5 ENSG00000253598 Solute carrier family 10, member 5 8 81693607-81696174 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA025966 Uncertain Approved Plasma membrane Mixed liver: 3.0 SLC10A7 C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043 ENSG00000120519 Solute carrier family 10, member 7 4 146253975-146521964 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039996, HPA057906 Uncertain Approved Nucleoli Mixed epididymis: 16.0 SLC11A1 LSH, NRAMP, NRAMP1 ENSG00000018280 Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 2 218382029-218396894 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029590 Uncertain Tissue enhanced 0 appendix: 9.3;lung: 13.2 spleen: 4.8 SLC11A2 DCT1, DMT1, NRAMP2 ENSG00000110911 Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 12 50979401-51028566 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032139, HPA032140 Uncertain Supported Mitochondria Expressed in all thyroid gland: 74.8 SLC12A1 NKCC2 ENSG00000074803 Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 15 48191664-48304078 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014967, HPA018107 Supported Tissue enriched 456 kidney: 773.2 testis: 1.6 SLC12A2 BSC, BSC2, NKCC1, PPP1R141 ENSG00000064651 Solute carrier family 12 (sodium/potassium/chloride transporter), member 2 5 128083766-128189688 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020130, HPA063697 Approved Approved Vesicles
Plasma membrane Expressed in all rectum: 66.4 SLC12A3 NCCT ENSG00000070915 Solute carrier family 12 (sodium/chloride transporter), member 3 16 56865207-56915850 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028748 Supported Tissue enriched 107 kidney: 109.3 lymph node: 1.0 SLC12A4 KCC1 ENSG00000124067 Solute carrier family 12 (potassium/chloride transporter), member 4 16 67943474-67969601 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041138 Approved Approved Endosomes Expressed in all parathyroid gland: 62.5 SLC12A5 KCC2, KIAA1176 ENSG00000124140 Solute carrier family 12 (potassium/chloride transporter), member 5 20 46021690-46060152 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA072058 Supported Tissue enriched 8 cerebral cortex: 94.5 adrenal gland: 12.0 SLC12A6 ACCPN, KCC3 ENSG00000140199 Solute carrier family 12 (potassium/chloride transporter), member 6 15 34229996-34338060 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034563 Uncertain Approved Vesicles
Cytosol Mixed testis: 46.2 SLC12A7 DKFZP434F076, KCC4 ENSG00000113504 Solute carrier family 12 (potassium/chloride transporter), member 7 5 1050376-1112035 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041652 Approved Uncertain Cytosol Mixed duodenum: 25.0 SLC12A8 CCC9 ENSG00000221955 Solute carrier family 12, member 8 3 125082636-125212864 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA031123 Uncertain Supported Nucleoplasm Tissue enhanced 0 thyroid gland: 39.4 gallbladder: 16.3 SLC12A9 CIP1 ENSG00000146828 Solute carrier family 12, member 9 7 100826820-100867009 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed placenta: 20.0 SLC13A1 NAS1, NaSi-1 ENSG00000081800 Solute carrier family 13 (sodium/sulfate symporter), member 1 7 123113531-123199986 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA053615, HPA062714 Approved Tissue enriched 6 kidney: 84.4 small intestine: 14.3 SLC13A2 NaDC-1 ENSG00000007216 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 17 28473293-28497781 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014963 Supported Tissue enhanced 0 duodenum: 70.6;small intestine: 55.4 kidney: 19.6 SLC13A3 NADC3, SDCT2 ENSG00000158296 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 20 46557823-46684467 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014353, HPA014736 Supported Tissue enriched 7 kidney: 428.6 placenta: 60.6 SLC13A4 SUT-1, SUT1 ENSG00000164707 Solute carrier family 13 (sodium/sulfate symporter), member 4 7 135681237-135729258 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA048582 Approved Tissue enriched 10 placenta: 76.2 testis: 7.3 SLC13A5 NACT ENSG00000141485 Solute carrier family 13 (sodium-dependent citrate transporter), member 5 17 6684713-6713567 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044343, HPA057088 Approved Uncertain Nucleoplasm Tissue enriched 9 liver: 118.1 salivary gland: 12.8 SLC15A1 HPECT1, HPEPT1, PEPT1 ENSG00000088386 Solute carrier family 15 (oligopeptide transporter), member 1 13 98683801-98752654 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA002827 Uncertain Approved Nucleoplasm
Cytosol Group enriched 5 duodenum: 157.7;gallbladder: 68.0;small intestine: 230.1 skin: 27.9 SLC15A2 PEPT2 ENSG00000163406 Solute carrier family 15 (oligopeptide transporter), member 2 3 121894089-121944102 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cervix, uterine: 77.7;prostate: 66.0 epididymis: 47.2 SLC15A3 hPTR3, PHT2 ENSG00000110446 Solute carrier family 15 (oligopeptide transporter), member 3 11 60937083-60952530 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA047880, HPA057642 Approved Supported Vesicles Expressed in all lung: 102.3 SLC15A4 PHT1, PTR4 ENSG00000139370 Solute carrier family 15 (oligopeptide transporter), member 4 12 128793191-128823983 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA016713 Approved Expressed in all lymph node: 27.7 SLC15A5 ENSG00000188991 Solute carrier family 15, member 5 12 16188485-16277685 Predicted membrane proteins, Transporters No evidence No evidence No evidence HPA041638 Uncertain Not detected testis: 0.3 SLC16A1 MCT, MCT1 ENSG00000155380 Solute carrier family 16 (monocarboxylate transporter), member 1 1 112911847-112957013 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003324, CAB017489, HPA071055 Supported Validated Plasma membrane
Cell Junctions Mixed testis: 32.0 SLC16A10 MCT10, TAT1 ENSG00000112394 Solute carrier family 16 (aromatic amino acid transporter), member 10 6 111087503-111231194 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016860 Approved Approved Vesicles
Cell Junctions Tissue enhanced 0 placenta: 38.2 skin: 22.5 SLC16A11 FLJ90193, MCT11 ENSG00000174326 Solute carrier family 16, member 11 17 7041630-7043923 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 fallopian tube: 8.8;parathyroid gland: 11.2 seminal vesicle: 3.8 SLC16A13 MCT13 ENSG00000174327 Solute carrier family 16, member 13 17 7036075-7040121 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA065245 Supported Golgi apparatus Mixed liver: 15.4 SLC16A14 FLJ30794, MCT14 ENSG00000163053 Solute carrier family 16, member 14 2 230034974-230068999 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA040518 Uncertain Approved Cytosol Mixed parathyroid gland: 14.6 SLC16A2 AHDS, DXS128, MCT7, MCT8, MRX22, XPCT ENSG00000147100 Solute carrier family 16, member 2 (thyroid hormone transporter) X 74421461-74533917 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA072719 Approved Plasma membrane Mixed liver: 41.9 SLC16A3 MCT3, MCT4 ENSG00000141526 Solute carrier family 16 (monocarboxylate transporter), member 3 17 82228397-82261129 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017490, HPA021451 Approved Supported Nuclear membrane
Plasma membrane Expressed in all skeletal muscle: 74.4 SLC16A5 MCT5, MCT6 ENSG00000170190 Solute carrier family 16 (monocarboxylate transporter), member 5 17 75087727-75106162 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Mixed duodenum: 35.5 SLC16A6 MCT6, MCT7 ENSG00000108932 Solute carrier family 16, member 6 17 68267026-68291267 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054459, HPA066328 Uncertain Approved Vesicles Tissue enhanced 0 epididymis: 39.8 esophagus: 12.1 SLC16A7 MCT2 ENSG00000118596 Solute carrier family 16 (monocarboxylate transporter), member 7 12 59596067-59789855 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005911 Approved Approved Nucleoplasm
Plasma membrane Mixed adipose tissue: 24.8 SLC16A8 MCT3, REMP ENSG00000100156 Solute carrier family 16 (monocarboxylate transporter), member 8 22 38078134-38084093 Plasma proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA075017 Approved Intermediate filaments
Focal adhesion sites Mixed prostate: 5.7 SLC16A9 C10orf36, FLJ43803, MCT9 ENSG00000165449 Solute carrier family 16, member 9 10 59650761-59736002 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA049286 Approved Approved Nucleus
Cell Junctions Tissue enhanced 0 adrenal gland: 199.5;kidney: 199.2 spleen: 57.0 SLC17A1 NAPI-1, NPT1 ENSG00000124568 Solute carrier family 17 (organic anion transporter), member 1 6 25782897-25832059 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA050513 Approved Golgi apparatus Tissue enriched 7 kidney: 173.1 liver: 25.2 SLC17A2 NPT3 ENSG00000112337 Solute carrier family 17, member 2 6 25912754-25930726 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA038270 Uncertain Tissue enriched 85 liver: 40.9 testis: 0.4 SLC17A3 NPT4 ENSG00000124564 Solute carrier family 17 (organic anion transporter), member 3 6 25833066-25882286 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016569 Uncertain Tissue enriched 9 kidney: 167.2 liver: 18.5 SLC17A4 KIAA2138 ENSG00000146039 Solute carrier family 17, member 4 6 25754699-25781191 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055564 Approved Group enriched 6 colon: 20.8;duodenum: 29.4;gallbladder: 25.5;liver: 22.4;rectum: 29.4;small intestine: 35.7 pancreas: 4.2 SLC17A6 DNPI, VGLUT2 ENSG00000091664 Solute carrier family 17 (vesicular glutamate transporter), member 6 11 22338097-22379503 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037130, HPA039226 Supported Supported Tissue enriched 65 cerebral cortex: 6.5 epididymis: 0.0 SLC17A7 BNPI, VGLUT1 ENSG00000104888 Solute carrier family 17 (vesicular glutamate transporter), member 7 19 49429401-49442360 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037183, HPA050458, HPA063679 Supported Tissue enriched 178 cerebral cortex: 586.2 adipose tissue: 3.2 SLC17A8 DFNA25, VGLUT3 ENSG00000179520 Solute carrier family 17 (vesicular glutamate transporter), member 8 12 100357079-100422059 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 small intestine: 5.9 cerebral cortex: 1.3 SLC17A9 C20orf59, FLJ23412, VNUT ENSG00000101194 Solute carrier family 17 (vesicular nucleotide transporter), member 9 20 62952647-62969585 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA047470, HPA056499 Uncertain Approved Nucleoplasm Mixed stomach: 8.7 SLC18A1 CGAT, VAT1, VMAT1 ENSG00000036565 Solute carrier family 18 (vesicular monoamine transporter), member 1 8 20144855-20183206 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA006877, HPA063797 Supported Tissue enriched 10 adrenal gland: 32.8 rectum: 3.1 SLC18A2 SVAT, SVMT, VMAT2 ENSG00000165646 Solute carrier family 18 (vesicular monoamine transporter), member 2 10 117241093-117279430 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cervix, uterine: 43.2 adrenal gland: 19.1 SLC18A3 VACHT ENSG00000187714 Solute carrier family 18 (vesicular acetylcholine transporter), member 3 10 49610301-49612720 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB037102 Uncertain Not detected placenta: 0.6 SLC18B1 C6orf192, dJ55C23.6 ENSG00000146409 Solute carrier family 18, subfamily B, member 1 6 132769370-132798553 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029747, HPA049659 Approved Supported Golgi apparatus
Cytosol Expressed in all cerebral cortex: 37.6 SLC19A1 FOLT ENSG00000173638 Solute carrier family 19 (folate transporter), member 1 21 45493572-45544411 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024802 Approved Approved Plasma membrane Mixed duodenum: 22.6 SLC19A2 THTR1, TRMA ENSG00000117479 Solute carrier family 19 (thiamine transporter), member 2 1 169463909-169486003 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006119, HPA016599 Uncertain Approved Cytosol Expressed in all gallbladder: 49.3 SLC19A3 THTR2 ENSG00000135917 Solute carrier family 19 (thiamine transporter), member 3 2 227685210-227718012 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038898 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 adipose tissue: 50.1;placenta: 34.5 duodenum: 12.7 SLC1A1 EAAC1, EAAT3 ENSG00000106688 Solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 9 4490444-4587469 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015466, HPA020086 Approved Tissue enhanced 0 small intestine: 72.7 epididymis: 53.8 SLC1A2 EAAT2, GLT-1 ENSG00000110436 Solute carrier family 1 (glial high affinity glutamate transporter), member 2 11 35251206-35420063 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002574, HPA009172 Supported Tissue enriched 30 cerebral cortex: 367.1 liver: 12.2 SLC1A3 EA6, EAAT1, GLAST ENSG00000079215 Solute carrier family 1 (glial high affinity glutamate transporter), member 3 5 36606355-36688334 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002573, HPA037467, HPA037468 Supported Approved Nucleoli
Mitochondria Tissue enriched 16 cerebral cortex: 519.6 adipose tissue: 31.7 SLC1A4 ASCT1, SATT ENSG00000115902 Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 2 64988477-65023865 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034963, HPA034964 Approved Validated Microtubule organizing center
Centrosome Expressed in all cerebral cortex: 79.3 SLC1A5 AAAT, ASCT2, M7V1, RDRC ENSG00000105281 Solute carrier family 1 (neutral amino acid transporter), member 5 19 46774883-46788594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035239, HPA035240 Supported Validated Plasma membrane Expressed in all epididymis: 117.4 SLC1A6 EAAT4 ENSG00000105143 Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 19 14950034-15022990 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041505, HPA044066 Supported Uncertain Intermediate filaments Group enriched 6 cerebral cortex: 16.2;skin: 8.9;testis: 36.8 epididymis: 3.7 SLC1A7 EAAT5 ENSG00000162383 Solute carrier family 1 (glutamate transporter), member 7 1 53087179-53142632 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 8.5 fallopian tube: 4.4 SLC20A1 Glvr-1, GLVR1, PiT-1 ENSG00000144136 Solute carrier family 20 (phosphate transporter), member 1 2 112645857-112663827 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019279, HPA035834 Approved Approved Vesicles Expressed in all colon: 51.9 SLC20A2 Glvr-2, GLVR2, MLVAR, PiT-2 ENSG00000168575 Solute carrier family 20 (phosphate transporter), member 2 8 42416475-42541926 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026540 Approved Expressed in all thyroid gland: 137.7 SLC22A1 OCT1 ENSG00000175003 Solute carrier family 22 (organic cation transporter), member 1 6 160121789-160158718 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029846 Approved Tissue enriched 252 liver: 286.8 gallbladder: 1.1 SLC22A10 hOAT5, OAT5 ENSG00000184999 Solute carrier family 22, member 10 11 63137867-63369718 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 108 liver: 36.1 epididymis: 0.3 SLC22A11 OAT4 ENSG00000168065 Solute carrier family 22 (organic anion/urate transporter), member 11 11 64555626-64572875 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026076 Approved Group enriched 134 epididymis: 10.0;kidney: 25.9;placenta: 44.5 seminal vesicle: 0.2 SLC22A12 OAT4L, RST, URAT1 ENSG00000197891 Solute carrier family 22 (organic anion/urate transporter), member 12 11 64590641-64602353 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024575 Supported Tissue enriched 195 kidney: 104.6 adipose tissue: 0.5 SLC22A13 OAT10, OCTL1, OCTL3, ORCTL3 ENSG00000172940 Solute carrier family 22 (organic anion/urate transporter), member 13 3 38265812-38278315 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA035603, HPA035962 Supported Tissue enriched 39 kidney: 10.6 testis: 0.2 SLC22A14 OCTL2, ORCTL4 ENSG00000144671 Solute carrier family 22, member 14 3 38282294-38318575 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 20 testis: 13.4 kidney: 0.6 SLC22A15 FLIPT1 ENSG00000163393 Solute carrier family 22, member 15 1 115976498-116070054 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019785 Approved Approved Vesicles Tissue enhanced 0 bone marrow: 20.5 skin: 11.1 SLC22A17 BOCT, BOIT, NGALR ENSG00000092096 Solute carrier family 22, member 17 14 23346306-23352912 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA002728 Uncertain Tissue enriched 6 cerebral cortex: 229.2 prostate: 38.6 SLC22A18 BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5 ENSG00000110628 Solute carrier family 22, member 18 11 2899721-2925246 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067812, HPA071461 Approved Tissue enhanced 0 duodenum: 44.5;small intestine: 32.4 colon: 10.5 SLC22A2 OCT2 ENSG00000112499 Solute carrier family 22 (organic cation transporter), member 2 6 160171061-160277638 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008567, CAB068236, CAB068237 Supported Tissue enriched 83 kidney: 149.2 seminal vesicle: 1.7 SLC22A23 C6orf85, FLJ22174 ENSG00000137266 Solute carrier family 22, member 23 6 3268962-3457022 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014697 Approved Approved Nucleoplasm
Vesicles
Cytosol Expressed in all stomach: 28.2 SLC22A24 MGC34821, NET46 ENSG00000197658 Solute carrier family 22, member 24 11 63079940-63144221 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045015 Uncertain Tissue enriched 46 kidney: 4.6 adipose tissue: 0.0 SLC22A25 HIMTP, MGC120420, UST6 ENSG00000196600 Solute carrier family 22, member 25 11 63163776-63229652 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039390 Uncertain Tissue enriched 57 liver: 5.7 epididymis: 0.0 SLC22A3 EMT, OCT3 ENSG00000146477 Solute carrier family 22 (organic cation transporter), member 3 6 160348268-160452581 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029750 Approved Approved Nucleoplasm
Vesicles
Cytosol Mixed seminal vesicle: 70.0 SLC22A4 MGC34546, OCTN1 ENSG00000197208 Solute carrier family 22 (organic cation/zwitterion transporter), member 4 5 132294443-132344206 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB015468, HPA036973 Approved Uncertain Nucleoplasm
Cytosol Tissue enhanced 0 fallopian tube: 18.6 bone marrow: 13.2 SLC22A5 CDSP, OCTN2, SCD ENSG00000197375 Solute carrier family 22 (organic cation/carnitine transporter), member 5 5 132369752-132395614 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA063062 Approved Mitochondria Mixed parathyroid gland: 31.4 SLC22A6 OAT1, PAHT, ROAT1 ENSG00000197901 Solute carrier family 22 (organic anion transporter), member 6 11 62936385-62984983 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 63 kidney: 199.6 cerebral cortex: 3.1 SLC22A7 NLT, OAT2 ENSG00000137204 Solute carrier family 22 (organic anion transporter), member 7 6 43295694-43305538 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030220 Approved Group enriched 63 kidney: 50.1;liver: 167.4 testis: 1.7 SLC22A8 OAT3 ENSG00000149452 Solute carrier family 22 (organic anion transporter), member 8 11 62989154-63015839 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044174 Supported Tissue enriched 391 kidney: 337.6 cerebral cortex: 0.8 SLC22A9 FLJ23666, OAT4, OAT7, UST3 ENSG00000149742 Solute carrier family 22 (organic anion transporter), member 9 11 63369789-63410294 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 30 liver: 22.8 skeletal muscle: 0.7 SLC23A1 SLC23A2, SVCT1, YSPL3 ENSG00000170482 Solute carrier family 23 (ascorbic acid transporter), member 1 5 139367196-139384553 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047612 Supported Group enriched 5 duodenum: 27.5;fallopian tube: 85.7;kidney: 41.7;small intestine: 73.4 liver: 10.7 SLC23A2 KIAA0238, SLC23A1, SVCT2, YSPL2 ENSG00000089057 Solute carrier family 23 (ascorbic acid transporter), member 2 20 4852356-5010293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052825, HPA059314 Approved Supported Golgi apparatus
Vesicles Expressed in all adrenal gland: 98.6 SLC23A3 FLJ31168, SVCT3, Yspl1 ENSG00000213901 Solute carrier family 23, member 3 2 219161465-219170095 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA019059 Approved Nucleus
Cell Junctions Tissue enhanced 0 kidney: 52.7;small intestine: 23.3 duodenum: 9.0 SLC24A1 CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX ENSG00000074621 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 15 65611366-65660995 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039370 Supported Approved Microtubules Mixed fallopian tube: 8.7 SLC24A2 NCKX2 ENSG00000155886 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 9 19507452-19786928 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 7 cerebral cortex: 51.8 adrenal gland: 7.9 SLC24A3 ENSG00000185052 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 20 19212646-19722937 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA043400, HPA045497 Uncertain Mixed endometrium: 47.4 SLC24A4 NCKX4 ENSG00000140090 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 14 92322581-92501483 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 7.1 spleen: 2.7 SLC24A5 JSX, OCA6 ENSG00000188467 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5 15 48120972-48142672 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 22 skin: 9.6;testis: 3.0 breast: 0.2 SLC25A1 CTP, SLC20A3 ENSG00000100075 Solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 22 19175575-19178830 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all duodenum: 115.9 SLC25A10 DIC ENSG00000183048 Solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 17 81712236-81721016 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023048 Supported Supported Nucleoplasm
Mitochondria Mixed kidney: 35.3 SLC25A11 OGC, SLC20A4 ENSG00000108528 Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 17 4937130-4940251 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021167 Approved Expressed in all heart muscle: 148.2 SLC25A12 Aralar ENSG00000115840 Solute carrier family 25 (aspartate/glutamate carrier), member 12 2 171784370-171999859 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035333, HPA035334 Supported Mixed skeletal muscle: 55.3 SLC25A13 ARALAR2, CITRIN, CTLN2 ENSG00000004864 Solute carrier family 25 (aspartate/glutamate carrier), member 13 7 96120220-96322147 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018997 Approved Supported Mitochondria Expressed in all liver: 77.3 SLC25A14 BMCP1, UCP5 ENSG00000102078 Solute carrier family 25 (mitochondrial carrier, brain), member 14 X 130339888-130373361 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA060316 Approved Mitochondria Mixed cerebral cortex: 20.5 SLC25A15 D13S327, HHH, ORC1, ORNT1 ENSG00000102743 Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 13 40789412-40810111 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042146 Approved Expressed in all liver: 49.6 SLC25A16 D10S105E, GDA, HGT.1, ML7 ENSG00000122912 Solute carrier family 25 (mitochondrial carrier), member 16 10 68477999-68527474 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036243, HPA044580 Uncertain Approved Mitochondria Mixed prostate: 13.7 SLC25A17 PMP34 ENSG00000100372 Solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 22 40769630-40819399 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052708, HPA060972 Approved Supported Peroxisomes Expressed in all ovary: 24.0 SLC25A18 ENSG00000182902 Solute carrier family 25 (glutamate carrier), member 18 22 17563439-17590994 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 74.7;liver: 25.2 adipose tissue: 14.0 SLC25A19 DNC, MCPHA, MUP1, TPC ENSG00000125454 Solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 17 75272981-75289510 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all testis: 49.5 SLC25A2 ORNT2 ENSG00000120329 Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2 5 141302629-141304045 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA042146 Uncertain Tissue enriched 116 testis: 11.6 epididymis: 0.0 SLC25A20 CAC, CACT ENSG00000178537 Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 3 48856931-48898993 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016862, HPA029863 Approved Supported Mitochondria
Cytosol Expressed in all liver: 70.8 SLC25A21 ODC, ODC1 ENSG00000183032 Solute carrier family 25 (mitochondrial oxoadipate carrier), member 21 14 36677921-37172866 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000662 Uncertain Mixed testis: 7.6 SLC25A22 EIEE3, FLJ13044, GC1, NET44 ENSG00000177542 Solute carrier family 25 (mitochondrial carrier: glutamate), member 22 11 790475-798333 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014662 Approved Validated Nucleoplasm
Mitochondria Tissue enriched 6 cerebral cortex: 89.9 testis: 15.2 SLC25A23 APC2, FLJ30339, MGC2615 ENSG00000125648 Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 19 6436079-6465203 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009675, HPA050883 Approved Supported Mitochondria Mixed cerebral cortex: 141.8 SLC25A24 APC1, DKFZp586G0123 ENSG00000085491 Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 1 108134036-108200849 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028519, HPA063636 Supported Validated Mitochondria Expressed in all cervix: 44.3 SLC25A26 ENSG00000144741 Solute carrier family 25 (S-adenosylmethionine carrier), member 26 3 66133610-66388116 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA026887 Supported Supported Mitochondria Expressed in all thyroid gland: 17.4 SLC25A27 FLJ33552, UCP4 ENSG00000153291 Solute carrier family 25, member 27 6 46652915-46678193 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA069732 Supported Mitochondria Mixed epididymis: 83.8 SLC25A28 MRS3/4, MRS4L ENSG00000155287 Solute carrier family 25 (mitochondrial iron transporter), member 28 10 99610522-99620609 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Expressed in all testis: 93.2 SLC25A29 C14orf69, FLJ38975 ENSG00000197119 Solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 14 100291111-100306547 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030781 Uncertain Expressed in all thyroid gland: 158.5 SLC25A3 PHC ENSG00000075415 Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 12 98593591-98606379 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045709 Supported Mitochondria Expressed in all parathyroid gland: 583.9 SLC25A30 ENSG00000174032 Solute carrier family 25, member 30 13 45393316-45418455 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045260 Approved Nucleoplasm Expressed in all kidney: 43.2 SLC25A31 ANT4, DKFZP434N1235 ENSG00000151475 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 4 127730378-127774299 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA015064, HPA016841, HPA046835, HPA071684 Uncertain Validated Mitochondria Tissue enriched 849 testis: 84.9 epididymis: 0.0 SLC25A32 MFTC ENSG00000164933 Solute carrier family 25 (mitochondrial folate carrier), member 32 8 103398635-103415189 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024763, HPA047402 Uncertain Supported Mitochondria Expressed in all lymph node: 21.3 SLC25A33 BMSC-MCP, MGC4399, PNC1 ENSG00000171612 Solute carrier family 25 (pyrimidine nucleotide carrier), member 33 1 9539482-9585179 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049982 Uncertain Mixed testis: 22.0 SLC25A34 DKFZp781A10161 ENSG00000162461 Solute carrier family 25, member 34 1 15736405-15741396 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA069806 Supported Mitochondria Tissue enhanced 0 duodenum: 14.9;small intestine: 15.5 skeletal muscle: 8.2 SLC25A35 FLJ40217 ENSG00000125434 Solute carrier family 25, member 35 17 8287763-8295343 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051720 Uncertain Approved Vesicles
Mitochondria Mixed testis: 19.6 SLC25A36 FLJ10618, PNC2 ENSG00000114120 Solute carrier family 25 (pyrimidine nucleotide carrier), member 36 3 140941830-140979933 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027036 Approved Approved Nucleus
Mitochondria
Cytosol Expressed in all parathyroid gland: 68.3 SLC25A37 MFRN, MFRN1, MSCP ENSG00000147454 Solute carrier family 25 (mitochondrial iron transporter), member 37 8 23528805-23575463 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045680 Uncertain Expressed in all bone marrow: 80.2 SLC25A38 FLJ20551 ENSG00000144659 Solute carrier family 25, member 38 3 39383348-39397351 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041027 Approved Expressed in all thyroid gland: 65.8 SLC25A39 CGI-69, FLJ22407 ENSG00000013306 Solute carrier family 25, member 39 17 44319625-44324870 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA026785 Approved Expressed in all bone marrow: 181.5 SLC25A4 ANT1, PEO2, PEO3, T1 ENSG00000151729 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 4 185143241-185150382 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046835, HPA071684 Approved Supported Mitochondria Tissue enhanced 0 heart muscle: 119.0;skeletal muscle: 66.2 cerebral cortex: 38.2 SLC25A40 MCFP ENSG00000075303 Solute carrier family 25, member 40 7 87833568-87876357 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055197 Uncertain Mixed prostate: 13.6 SLC25A41 APC4, FLJ40442, MGC34725 ENSG00000181240 Solute carrier family 25, member 41 19 6426037-6433779 Predicted intracellular proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043591 Uncertain Tissue enhanced 0 cerebral cortex: 1.0;testis: 1.9 esophagus: 0.4 SLC25A42 MGC26694 ENSG00000181035 Solute carrier family 25, member 42 19 19063999-19112888 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA049449 Approved Supported Mitochondria Expressed in all kidney: 28.7 SLC25A43 ENSG00000077713 Solute carrier family 25, member 43 X 119399060-119454478 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035188 Uncertain Approved Nucleus Mixed esophagus: 20.6 SLC25A44 FLJ90431, KIAA0446 ENSG00000160785 Solute carrier family 25, member 44 1 156193932-156212796 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA065411 Approved Nucleus
Mitochondria Expressed in all cerebral cortex: 43.1 SLC25A45 ENSG00000162241 Solute carrier family 25, member 45 11 65375192-65383701 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA050821 Uncertain Approved Nucleoplasm
Cytosol Expressed in all spleen: 12.6 SLC25A46 ENSG00000164209 Solute carrier family 25, member 46 5 110738136-110765161 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039601, HPA071582 Approved Supported Mitochondria Expressed in all testis: 37.3 SLC25A47 C14orf68 ENSG00000140107 Solute carrier family 25, member 47 14 100323337-100330378 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 166 liver: 101.0 duodenum: 0.6 SLC25A48 FLJ44862, HDMCP ENSG00000145832 Solute carrier family 25, member 48 5 135834649-135888637 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014674 Uncertain Approved Intermediate filaments
Actin filaments Tissue enhanced 0 cerebral cortex: 17.7;kidney: 7.3 skeletal muscle: 2.7 SLC25A5 2F1, ANT2, T2, T3 ENSG00000005022 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 X 119468400-119471319 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046835, HPA071684 Approved Supported Mitochondria Expressed in all duodenum: 791.0 SLC25A51 CG7943, MCART1, MGC14836 ENSG00000122696 Solute carrier family 25, member 51 9 37879400-37904353 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046388, HPA058261 Uncertain Approved Mitochondria Expressed in all parathyroid gland: 16.4 SLC25A6 ANT3, ANT3Y, MGC17525 ENSG00000169100 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 X 1386152-1392724 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046835, HPA071684 Approved Supported Mitochondria Expressed in all duodenum: 294.5 SLC26A1 EDM4, SAT-1 ENSG00000145217 Solute carrier family 26 (anion exchanger), member 1 4 979073-993440 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041654 Uncertain Approved Microtubules Mixed kidney: 6.1 SLC26A10 ENSG00000135502 Solute carrier family 26, member 10 12 57619527-57626151 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044719 Uncertain Not detected endometrium: 0.5 SLC26A11 ENSG00000181045 Solute carrier family 26 (anion exchanger), member 11 17 80219699-80253500 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA029893 Approved Supported Nucleoplasm
Golgi apparatus
Vesicles Expressed in all adrenal gland: 34.5 SLC26A2 DTD, DTDST ENSG00000155850 Solute carrier family 26 (anion exchanger), member 2 5 149960737-149993455 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041957, HPA058090 Supported Approved Vesicles Tissue enhanced 0 colon: 215.9;rectum: 209.8 parathyroid gland: 81.4 SLC26A3 CLD, DRA ENSG00000091138 Solute carrier family 26 (anion exchanger), member 3 7 107765467-107803225 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036055 Approved Tissue enhanced 0 colon: 1092.5;duodenum: 594.0;rectum: 974.8 seminal vesicle: 183.9 SLC26A4 DFNB4, PDS ENSG00000091137 Solute carrier family 26 (anion exchanger), member 4 7 107660635-107717809 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042860 Approved Tissue enriched 28 thyroid gland: 422.9 cerebral cortex: 15.2 SLC26A5 DFNB61, PRES ENSG00000170615 Solute carrier family 26 (anion exchanger), member 5 7 103352730-103446177 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Mixed breast: 1.2 SLC26A6 DKFZp586E1422 ENSG00000225697 Solute carrier family 26 (anion exchanger), member 6 3 48625723-48635493 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048363 Approved Uncertain Cytosol Expressed in all rectum: 24.3 SLC26A8 ENSG00000112053 Solute carrier family 26 (anion exchanger), member 8 6 35943514-36024868 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038080, HPA038081 Uncertain Tissue enriched 27 testis: 75.6 bone marrow: 2.8 SLC26A9 ENSG00000174502 Solute carrier family 26 (anion exchanger), member 9 1 205913048-205943460 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051485 Approved Approved Nucleus
Cell Junctions Tissue enhanced 0 salivary gland: 31.7;stomach: 30.4 lung: 11.4 SLC28A1 CNT1 ENSG00000156222 Solute carrier family 28 (concentrative nucleoside transporter), member 1 15 84884654-84945796 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019551 Supported Group enriched 26 duodenum: 39.0;kidney: 49.1;liver: 35.4;small intestine: 54.7 placenta: 1.6 SLC28A2 CNT2, HCNT2, HsT17153, SPNT1 ENSG00000137860 Solute carrier family 28 (concentrative nucleoside transporter), member 2 15 45252230-45277845 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA046068, HPA055623 Supported Tissue enhanced 0 duodenum: 66.8;rectum: 37.9;small intestine: 100.1 stomach: 21.4 SLC28A3 CNT3 ENSG00000197506 Solute carrier family 28 (concentrative nucleoside transporter), member 3 9 84275457-84340683 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA023311, HPA024729 Approved Tissue enhanced 0 breast: 10.7;gallbladder: 11.7;skin: 9.8 bone marrow: 6.2 SLC29A1 ENT1 ENSG00000112759 Solute carrier family 29 (equilibrative nucleoside transporter), member 1 6 44219505-44234151 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012384 Approved Expressed in all adrenal gland: 125.1 SLC29A2 DER12, ENT2, HNP36 ENSG00000174669 Solute carrier family 29 (equilibrative nucleoside transporter), member 2 11 66362521-66372214 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018168 Approved Uncertain Nucleoplasm Tissue enhanced 0 skeletal muscle: 36.4 parathyroid gland: 21.8 SLC29A3 ENT3, FLJ11160 ENSG00000198246 Solute carrier family 29 (equilibrative nucleoside transporter), member 3 10 71319258-71363385 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046085, HPA054976, HPA057905 Approved Supported Golgi apparatus
Vesicles Mixed placenta: 18.7 SLC29A4 ENT4, FLJ34923 ENSG00000164638 Solute carrier family 29 (equilibrative nucleoside transporter), member 4 7 5274369-5306870 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA052829 Supported Microtubules
Cytokinetic bridge Tissue enhanced 0 adipose tissue: 44.2 cerebral cortex: 12.0 SLC2A1 CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR ENSG00000117394 Solute carrier family 2 (facilitated glucose transporter), member 1 1 42925375-42959173 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002759, HPA031345, HPA058494 Supported Supported Validated Plasma membrane Tissue enhanced 0 placenta: 133.9 skin: 31.3 SLC2A10 GLUT10 ENSG00000197496 Solute carrier family 2 (facilitated glucose transporter), member 10 20 46709487-46736347 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041015, HPA055673 Approved Supported Cytosol Mixed prostate: 46.7 SLC2A11 GLUT10, GLUT11 ENSG00000133460 Solute carrier family 2 (facilitated glucose transporter), member 11 22 23856703-23886309 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042960, HPA071184 Uncertain Uncertain Nucleus
Cell Junctions Mixed parathyroid gland: 10.7 SLC2A12 GLUT12, GLUT8 ENSG00000146411 Solute carrier family 2 (facilitated glucose transporter), member 12 6 133988697-134052636 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA031593, HPA031594 Approved Validated Plasma membrane
Cell Junctions Tissue enhanced 0 prostate: 38.8 endometrium: 15.7 SLC2A13 HMIT ENSG00000151229 Solute carrier family 2 (facilitated glucose transporter), member 13 12 39755021-40106089 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006584 Approved Approved Nuclear membrane Tissue enhanced 0 cerebral cortex: 49.5;parathyroid gland: 73.3 cervix: 20.3 SLC2A14 GLUT14, SLC2A3P3 ENSG00000173262 Solute carrier family 2 (facilitated glucose transporter), member 14 12 7812512-7891148 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA006539 Approved Approved Plasma membrane Tissue enriched 9 testis: 151.1 breast: 17.2 SLC2A2 GLUT2 ENSG00000163581 Solute carrier family 2 (facilitated glucose transporter), member 2 3 170996348-171026750 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010444, HPA028997, HPA028998 Supported Approved Nucleoplasm Tissue enriched 6 liver: 432.5 duodenum: 67.5 SLC2A3 GLUT3 ENSG00000059804 Solute carrier family 2 (facilitated glucose transporter), member 3 12 7919230-7936275 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002763, HPA006539 Approved Approved Plasma membrane Tissue enhanced 0 bone marrow: 271.6 placenta: 137.6 SLC2A4 GLUT4 ENSG00000181856 Solute carrier family 2 (facilitated glucose transporter), member 4 17 7281667-7288257 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016544 Supported Tissue enhanced 0 heart muscle: 30.1;skeletal muscle: 45.0 adipose tissue: 21.9 SLC2A6 GLUT6, GLUT9, HSA011372 ENSG00000160326 Solute carrier family 2 (facilitated glucose transporter), member 6 9 133471095-133479137 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042272, CAB046014 Uncertain Mixed appendix: 6.3 SLC2A7 GLUT7 ENSG00000197241 Solute carrier family 2 (facilitated glucose transporter), member 7 1 9003300-9026345 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039931 Uncertain Group enriched 9 duodenum: 3.1;small intestine: 3.1 epididymis: 0.3 SLC2A8 GLUT8, GLUTX1 ENSG00000136856 Solute carrier family 2 (facilitated glucose transporter), member 8 9 127397138-127408424 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011935 Uncertain Approved Vesicles Expressed in all testis: 50.1 SLC2A9 Glut9, GLUTX, URATv1 ENSG00000109667 Solute carrier family 2 (facilitated glucose transporter), member 9 4 9771153-10054936 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA066229 Approved Tissue enhanced 0 kidney: 30.9;seminal vesicle: 29.4 duodenum: 11.1 SLC30A1 ZNT1, ZRC1 ENSG00000170385 Solute carrier family 30 (zinc transporter), member 1 1 211571568-211578742 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015275, HPA049000 Uncertain Supported Vesicles
Plasma membrane Mixed liver: 47.3 SLC30A10 DKFZp547M236, ZnT-10, ZNT8, ZRC1 ENSG00000196660 Solute carrier family 30, member 10 1 219685427-219958647 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017989 Uncertain Tissue enhanced 0 duodenum: 2.2;liver: 2.3 testis: 1.1 SLC30A2 ZNT2 ENSG00000158014 Solute carrier family 30 (zinc transporter), member 2 1 26037252-26046133 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA017979 Approved Vesicles Tissue enhanced 0 kidney: 21.9;thyroid gland: 42.3 pancreas: 16.5 SLC30A3 ZNT3 ENSG00000115194 Solute carrier family 30 (zinc transporter), member 3 2 27253684-27275817 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060505, HPA067637 Approved Approved Nucleus
Nucleoli
Vesicles
Cytosol Group enriched 14 cerebral cortex: 36.7;epididymis: 65.2;testis: 43.6 heart muscle: 3.4 SLC30A4 ZNT4 ENSG00000104154 Solute carrier family 30 (zinc transporter), member 4 15 45479611-45522807 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018178 Uncertain Tissue enriched 5 prostate: 64.1 testis: 11.8 SLC30A5 FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1 ENSG00000145740 Solute carrier family 30 (zinc transporter), member 5 5 69093646-69131069 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035373 Approved Supported Nucleus
Golgi apparatus Expressed in all thyroid gland: 61.6 SLC30A6 FLJ31101, ZNT6 ENSG00000152683 Solute carrier family 30 (zinc transporter), member 6 2 32165841-32224379 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055032, HPA057328 Uncertain Validated Golgi apparatus Expressed in all thyroid gland: 19.7 SLC30A7 ZNT7, ZnTL2 ENSG00000162695 Solute carrier family 30 (zinc transporter), member 7 1 100896076-100981753 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA018034 Uncertain Supported Golgi apparatus Mixed parathyroid gland: 20.6 SLC30A8 ENSG00000164756 Solute carrier family 30 (zinc transporter), member 8 8 116950273-117176714 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 pancreas: 13.2 salivary gland: 5.0 SLC30A9 C4orf1, GAC63, HUEL, ZNT9 ENSG00000014824 Solute carrier family 30 (zinc transporter), member 9 4 41990472-42090457 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004014 Approved Expressed in all parathyroid gland: 35.7 SLC32A1 bA122O1.1, VGAT, VIAAT ENSG00000101438 Solute carrier family 32 (GABA vesicular transporter), member 1 20 38724462-38729372 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037156, HPA058859, HPA059985 Supported Tissue enriched 34 cerebral cortex: 15.9 testis: 0.4 SLC33A1 ACATN, AT-1, AT1, SPG42 ENSG00000169359 Solute carrier family 33 (acetyl-CoA transporter), member 1 3 155821024-155854429 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042430 Uncertain Expressed in all thyroid gland: 67.1 SLC34A1 NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2 ENSG00000131183 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 1 5 177379235-177398848 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA051255 Approved Tissue enriched 164 kidney: 161.0 liver: 0.9 SLC34A2 NAPI-3B ENSG00000157765 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 2 4 25655301-25678748 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037989 Supported Tissue enriched 10 lung: 1127.5 fallopian tube: 111.7 SLC34A3 FLJ38680, NPTIIc ENSG00000198569 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 3 9 137230757-137236554 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023776 Supported Group enriched 14 kidney: 11.8;small intestine: 9.2 testis: 0.7 SLC35A1 CMPST, hCST ENSG00000164414 Solute carrier family 35 (CMP-sialic acid transporter), member A1 6 87470623-87512336 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Expressed in all prostate: 59.9 SLC35A2 UGALT, UGAT, UGT, UGT1, UGT2, UGTL ENSG00000102100 Solute carrier family 35 (UDP-galactose transporter), member A2 X 48903180-48911958 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036087 Approved Supported Golgi apparatus Expressed in all fallopian tube: 44.1 SLC35A3 ENSG00000117620 Solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 1 99969789-100026979 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015253 Uncertain Expressed in all rectum: 47.2 SLC35A4 ENSG00000176087 Solute carrier family 35, member A4 5 140564456-140569103 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA062210 Approved Nucleoplasm Expressed in all parathyroid gland: 110.8 SLC35A5 FLJ20730 ENSG00000138459 Solute carrier family 35, member A5 3 112561709-112585577 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035519, HPA057964 Uncertain Approved Golgi apparatus Expressed in all thyroid gland: 43.7 SLC35B1 UGTREL1 ENSG00000121073 Solute carrier family 35, member B1 17 49700943-49709014 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048655, HPA057418 Approved Approved Nucleus
Endoplasmic reticulum
Vesicles Expressed in all thyroid gland: 52.0 SLC35B2 UGTrel4 ENSG00000157593 Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B2 6 44254096-44257890 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029638 Approved Approved Vesicles Expressed in all parathyroid gland: 58.0 SLC35B3 C6orf196, CGI-19, dJ453H5.1, PAPST2 ENSG00000124786 Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 6 8413068-8435483 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054661, HPA057801 Approved Expressed in all epididymis: 62.2 SLC35C1 FLJ11320, FUCT1 ENSG00000181830 Solute carrier family 35 (GDP-fucose transporter), member C1 11 45804072-45813015 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064001 Supported Supported Golgi apparatus Expressed in all esophagus: 29.5 SLC35C2 bA394O2.1, C20orf5, CGI-15, OVCOV1 ENSG00000080189 Solute carrier family 35 (GDP-fucose transporter), member C2 20 46345980-46364458 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA027011 Approved Supported Nucleoplasm
Golgi apparatus Expressed in all fallopian tube: 36.6 SLC35D1 KIAA0260, UGTREL7 ENSG00000116704 Solute carrier family 35 (UDP-GlcA/UDP-GalNAc transporter), member D1 1 66999332-67054099 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all liver: 38.5 SLC35D2 SQV7L, UGTrel8 ENSG00000130958 Solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 9 96320706-96383710 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA064047 Approved Validated Golgi apparatus Expressed in all small intestine: 73.8 SLC35D3 FRCL1 ENSG00000182747 Solute carrier family 35, member D3 6 136922264-136925639 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030431, HPA067497 Uncertain Approved Microtubule organizing center Tissue enhanced 0 adrenal gland: 1.2 lung: 0.6 SLC35E1 FLJ14251 ENSG00000127526 Solute carrier family 35, member E1 19 16549831-16572382 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016570, HPA062214 Approved Validated Golgi apparatus Expressed in all parathyroid gland: 29.2 SLC35E2B ENSG00000189339 Solute carrier family 35, member E2B 1 1659529-1692728 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045641, HPA062711 Uncertain Uncertain Nucleus Expressed in all smooth muscle: 47.0 SLC35E3 BLOV1 ENSG00000175782 Solute carrier family 35, member E3 12 68746106-68793964 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049403 Uncertain Mixed skin: 6.1 SLC35E4 ENSG00000100036 Solute carrier family 35, member E4 22 30635652-30669016 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049558 Approved Approved Cytosol Tissue enhanced 0 testis: 17.6 cerebral cortex: 5.1 SLC35F1 C6orf169, dJ230I3.1 ENSG00000196376 Solute carrier family 35, member F1 6 117907526-118317676 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019576 Approved Approved Nucleoplasm
Microtubule organizing center
Cytosol Tissue enriched 12 cerebral cortex: 45.6 epididymis: 3.7 SLC35F2 FLJ13018 ENSG00000110660 Solute carrier family 35, member F2 11 107790991-107928293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048185, HPA050695 Uncertain Approved Mitochondria Mixed prostate: 33.0 SLC35F3 FLJ37712 ENSG00000183780 Solute carrier family 35, member F3 1 233904933-234324516 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051327, HPA061582 Uncertain Approved Nucleoli
Golgi apparatus Tissue enhanced 0 cerebral cortex: 10.2 breast: 3.0 SLC35F4 C14orf36, FLJ37712 ENSG00000151812 Solute carrier family 35, member F4 14 57563922-57982194 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043853 Uncertain Approved Nucleoli fibrillar center Tissue enhanced 0 prostate: 1.9;seminal vesicle: 4.9;testis: 1.8 thyroid gland: 1.0 SLC35F5 FLJ22004 ENSG00000115084 Solute carrier family 35, member F5 2 113705011-113756823 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034828, HPA049229 Uncertain Uncertain Plasma membrane Expressed in all thyroid gland: 65.7 SLC35F6 ANT2BP, C2orf18, FLJ20555, TANGO9 ENSG00000213699 Solute carrier family 35, member F6 2 26764284-26781231 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034655 Approved Approved Nucleoplasm
Vesicles
Cytosol Expressed in all thyroid gland: 26.2 SLC35G1 C10orf60, FLJ33990, TMEM20 ENSG00000176273 Solute carrier family 35, member G1 10 93893973-93956062 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 duodenum: 88.4;small intestine: 45.8 rectum: 7.9 SLC35G2 DKFZp564K2464, MGC3295, TMEM22 ENSG00000168917 Solute carrier family 35, member G2 3 136818647-136855892 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052054, HPA064728 Approved Approved Cytosol Mixed testis: 21.2 SLC35G3 AMAC1, FLJ40154, TMEM21A ENSG00000164729 Solute carrier family 35, member G3 17 35192520-35194523 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 15 testis: 1.6 skeletal muscle: 0.1 SLC35G5 AMAC, AMAC1L2 ENSG00000177710 Solute carrier family 35, member G5 8 11330888-11332208 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 testis: 1.5 spleen: 0.4 SLC35G6 AMAC1L3, TMEM21B ENSG00000259224 Solute carrier family 35, member G6 17 7481332-7483496 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 19 testis: 3.7 skeletal muscle: 0.1 SLC36A1 LYAAT-1, PAT1, TRAMD3 ENSG00000123643 Solute carrier family 36 (proton/amino acid symporter), member 1 5 151437046-151492381 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035937 Approved Tissue enhanced 0 parathyroid gland: 64.1 duodenum: 45.5 SLC36A2 PAT2, TRAMD1, tramdorin ENSG00000186335 Solute carrier family 36 (proton/amino acid symporter), member 2 5 151314978-151347590 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044002, HPA062229 Supported Group enriched 26 kidney: 67.2;skeletal muscle: 28.1 testis: 1.8 SLC36A3 PAT3, TRAMD2, tramdorin2 ENSG00000186334 Solute carrier family 36, member 3 5 151276762-151303766 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 57 testis: 14.4 epididymis: 0.2 SLC36A4 FLJ38932, PAT4 ENSG00000180773 Solute carrier family 36 (proton/amino acid symporter), member 4 11 93144171-93197964 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017887 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Mixed thyroid gland: 14.7 SLC37A1 ENSG00000160190 Solute carrier family 37 (glucose-6-phosphate transporter), member 1 21 42496008-42581440 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030418, CAB034154 Approved Approved Nucleus Mixed duodenum: 46.9 SLC37A2 FLJ00171 ENSG00000134955 Solute carrier family 37 (glucose-6-phosphate transporter), member 2 11 125063067-125090312 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014948 Uncertain Mixed adrenal gland: 24.8 SLC37A3 DKFZp761N0624 ENSG00000157800 Solute carrier family 37, member 3 7 140293693-140404433 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA014713, HPA061841 Supported Cytosol Expressed in all endometrium: 72.5 SLC38A1 ATA1, NAT2, SAT1 ENSG00000111371 Solute carrier family 38, member 1 12 46183063-46270017 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039460, HPA052272 Uncertain Supported Expressed in all parathyroid gland: 153.2 SLC38A10 MGC15523, PP1744 ENSG00000157637 Solute carrier family 38, member 10 17 81245000-81295547 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021374, HPA023161, HPA024631 Supported Validated Golgi apparatus Expressed in all thyroid gland: 44.6 SLC38A11 AVT2, FLJ39822 ENSG00000169507 Solute carrier family 38, member 11 2 164896186-164955525 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043432 Uncertain Tissue enhanced 0 epididymis: 47.1;gallbladder: 28.3 seminal vesicle: 23.3 SLC38A3 G17, SN1 ENSG00000188338 Solute carrier family 38, member 3 3 50205246-50221486 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031871 Approved Microtubules
Cytosol Tissue enriched 7 liver: 173.5 cerebral cortex: 25.6 SLC38A4 ATA3, NAT3, PAAT ENSG00000139209 Solute carrier family 38, member 4 12 46764761-46832408 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 40 liver: 346.5 smooth muscle: 8.6 SLC38A5 JM24, SN2 ENSG00000017483 Solute carrier family 38, member 5 X 48458537-48470256 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047411 Approved Approved Vesicles
Plasma membrane
Cytosol Mixed pancreas: 50.0 SLC38A6 NAT-1 ENSG00000139974 Solute carrier family 38, member 6 14 60981114-61083733 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018508 Approved Approved Plasma membrane
Cell Junctions
Microtubules Mixed parathyroid gland: 24.3 SLC38A7 FLJ10815 ENSG00000103042 Solute carrier family 38, member 7 16 58665109-58685104 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041777 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Mixed testis: 34.8 SLC38A8 ENSG00000166558 Solute carrier family 38, member 8 16 84009667-84042636 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Not detected testis: 0.9 SLC38A9 FLJ90709 ENSG00000177058 Solute carrier family 38, member 9 5 55625845-55773194 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043785 Uncertain Approved Nucleoplasm
Vesicles Expressed in all placenta: 79.8 SLC39A1 ZIP1, ZIRTL ENSG00000143570 Solute carrier family 39 (zinc transporter), member 1 1 153959099-153968184 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016506 Uncertain Cytosol Expressed in all placenta: 133.4 SLC39A10 DKFZp564L2123, FLJ90515, KIAA1265 ENSG00000196950 Solute carrier family 39 (zinc transporter), member 10 2 195575977-195737702 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036512, HPA036513, HPA066087 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 78.0;thyroid gland: 79.0 prostate: 27.6 SLC39A11 C17orf26 ENSG00000133195 Solute carrier family 39, member 11 17 72645949-73092712 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA021455 Approved Nucleoplasm Expressed in all thyroid gland: 60.0 SLC39A12 FLJ30499 ENSG00000148482 Solute carrier family 39 (zinc transporter), member 12 10 17951839-18043292 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 28 cerebral cortex: 25.4 breast: 0.8 SLC39A13 FLJ25785 ENSG00000165915 Solute carrier family 39 (zinc transporter), member 13 11 47407132-47416501 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA043971 Approved Uncertain Cytosol Expressed in all placenta: 58.0 SLC39A3 ZIP3 ENSG00000141873 Solute carrier family 39 (zinc transporter), member 3 19 2732204-2740152 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042139, HPA058526 Uncertain Approved Vesicles Expressed in all testis: 109.9 SLC39A5 ENSG00000139540 Solute carrier family 39 (zinc transporter), member 5 12 56230049-56237846 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018423 Approved Nucleoplasm
Vesicles
Cytosol Group enriched 12 colon: 74.5;duodenum: 247.0;kidney: 114.6;liver: 85.7;pancreas: 53.1;rectum: 49.7;small intestine: 245.4 gallbladder: 10.0 SLC39A6 LIV-1 ENSG00000141424 Solute carrier family 39 (zinc transporter), member 6 18 36108532-36129385 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042377 Approved Expressed in all prostate: 209.0 SLC39A7 D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7 ENSG00000112473 Solute carrier family 39 (zinc transporter), member 7 6 33200445-33204439 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053999 Approved Supported Endoplasmic reticulum Expressed in all parathyroid gland: 40.2 SLC39A8 BIGM103 ENSG00000138821 Solute carrier family 39 (zinc transporter), member 8 4 102251041-102431258 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA038832, HPA038833 Approved Tissue enhanced 0 lung: 257.1 cervix: 128.6 SLC39A9 FLJ11274 ENSG00000029364 Solute carrier family 39, member 9 14 69398015-69462388 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA007921, HPA075390 Approved Approved Endoplasmic reticulum Expressed in all parathyroid gland: 44.1 SLC40A1 FPN1, HFE4, IREG1, MTP1, SLC11A3 ENSG00000138449 Solute carrier family 40 (iron-regulated transporter), member 1 2 189560579-189583758 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065634 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Expressed in all spleen: 496.0 SLC43A1 PB39, POV1, R00504 ENSG00000149150 Solute carrier family 43 (amino acid system L transporter), member 1 11 57484534-57515786 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018813, HPA018826 Supported Approved Golgi apparatus
Vesicles
Plasma membrane Expressed in all liver: 50.0 SLC43A2 MGC34680 ENSG00000167703 Solute carrier family 43 (amino acid system L transporter), member 2 17 1569267-1628886 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021564 Approved Tissue enhanced 0 placenta: 31.6 appendix: 17.4 SLC43A3 DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1 ENSG00000134802 Solute carrier family 43, member 3 11 57406954-57427580 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030551 Approved Expressed in all thyroid gland: 121.6 SLC44A1 CD92, CDW92, CHTL1, CTL1 ENSG00000070214 Solute carrier family 44 (choline transporter), member 1 9 105244622-105439171 CD markers, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064714 Supported Nucleoplasm
Mitochondria Expressed in all cerebral cortex: 107.8 SLC44A2 CTL2 ENSG00000129353 Solute carrier family 44 (choline transporter), member 2 19 10602457-10644559 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003228, HPA070799 Approved Approved Vesicles
Cell Junctions Expressed in all placenta: 224.3 SLC44A3 CTL3, MGC45474 ENSG00000143036 Solute carrier family 44, member 3 1 94820342-94895246 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047433 Approved Mixed rectum: 39.1 SLC44A4 C6orf29, CTL4, FLJ14491, NG22, TPPT ENSG00000204385 Solute carrier family 44, member 4 6 31863192-31879046 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046977, HPA054176 Approved Tissue enhanced 0 duodenum: 36.0 prostate: 30.1 SLC44A5 CTL5, MGC34032 ENSG00000137968 Solute carrier family 44, member 5 1 75202131-75611116 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA047455, HPA051011 Uncertain Approved Cytosol Tissue enhanced 0 skin: 12.6 testis: 8.0 SLC45A1 DNB5 ENSG00000162426 Solute carrier family 45, member 1 1 8317826-8344167 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 11.7 endometrium: 3.2 SLC45A2 AIM-1, MATP, OCA4 ENSG00000164175 Solute carrier family 45, member 2 5 33944616-33984730 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 skin: 1.2;testis: 1.3 prostate: 0.3 SLC45A3 IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein ENSG00000158715 Solute carrier family 45, member 3 1 205657851-205680459 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019073, HPA019075 Supported Approved Nucleoplasm
Vesicles Tissue enriched 25 prostate: 430.6 stomach: 16.9 SLC45A4 KIAA1126 ENSG00000022567 Solute carrier family 45, member 4 8 141207166-141308305 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023154 Uncertain Approved Plasma membrane Mixed testis: 21.1 SLC46A1 HCP1, MGC9564, PCFT ENSG00000076351 Solute carrier family 46 (folate transporter), member 1 17 28394756-28407197 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011614 Approved Supported Plasma membrane
Cytosol Expressed in all duodenum: 97.7 SLC46A2 Ly110, TSCOT ENSG00000119457 Solute carrier family 46, member 2 9 112878920-112890913 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA020098 Approved Group enriched 6 cervix, uterine: 23.0;endometrium: 5.5;epididymis: 5.4;lung: 15.2;skin: 11.3 seminal vesicle: 2.0 SLC46A3 DKFZp686A1775, FLJ42613 ENSG00000139508 Solute carrier family 46, member 3 13 28700064-28718970 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039930 Uncertain Approved Plasma membrane
Actin filaments
Cytosol Expressed in all small intestine: 89.4 SLC47A1 FLJ10847, MATE1 ENSG00000142494 Solute carrier family 47 (multidrug and toxin extrusion), member 1 17 19495385-19579034 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021987 Supported Tissue enhanced 0 adrenal gland: 139.0;kidney: 105.0 liver: 55.2 SLC47A2 FLJ31196, MATE2, MATE2-K ENSG00000180638 Solute carrier family 47 (multidrug and toxin extrusion), member 2 17 19678288-19718979 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 fallopian tube: 16.0;kidney: 48.9 epididymis: 6.0 SLC48A1 FLJ20489, hHRG-1, HRG1 ENSG00000211584 Solute carrier family 48 (heme transporter), member 1 12 47753916-47782753 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA073994 Supported Vesicles Expressed in all thyroid gland: 79.4 SLC4A1 AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR ENSG00000004939 Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) 17 44248385-44268141 Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015584, CAB034438, HPA063911 Supported Tissue enriched 8 bone marrow: 238.4 kidney: 29.9 SLC4A10 NBCn2, NCBE ENSG00000144290 Solute carrier family 4, sodium bicarbonate transporter, member 10 2 161424332-161985282 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA034755 Supported Tissue enriched 22 cerebral cortex: 57.7 adrenal gland: 2.6 SLC4A11 BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1 ENSG00000088836 Solute carrier family 4, sodium borate transporter, member 11 20 3227417-3239190 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018120, HPA058377 Uncertain Uncertain Nucleoplasm
Vesicles Tissue enhanced 0 salivary gland: 19.3;thyroid gland: 27.6 cervix: 14.3 SLC4A2 AE2, BND3L, EPB3L1, HKB3, NBND3 ENSG00000164889 Solute carrier family 4 (anion exchanger), member 2 7 151057210-151076527 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019339 Supported Approved Nuclear speckles
Plasma membrane
Cytosol Expressed in all parathyroid gland: 87.8 SLC4A3 AE3, SLC2C ENSG00000114923 Solute carrier family 4 (anion exchanger), member 3 2 219627327-219641980 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA063498 Approved Nucleoplasm Group enriched 6 cerebral cortex: 30.1;heart muscle: 125.7;ovary: 47.6 testis: 10.9 SLC4A4 hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5 ENSG00000080493 Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 4 71187286-71572087 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022493, HPA035628, HPA035629 Supported Tissue enhanced 0 kidney: 124.6 cerebral cortex: 57.5 SLC4A7 NBC3, SBC2, SLC4A6 ENSG00000033867 Solute carrier family 4, sodium bicarbonate cotransporter, member 7 3 27372721-27484420 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022494, HPA035857 Supported Supported Plasma membrane
Focal adhesion sites Tissue enhanced 0 duodenum: 59.2 breast: 23.6 SLC4A9 AE4 ENSG00000113073 Solute carrier family 4, sodium bicarbonate cotransporter, member 9 5 140360202-140375143 Plasma proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051307 Uncertain Tissue enriched 17 kidney: 12.1 testis: 0.6 SLC50A1 HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1 ENSG00000169241 Solute carrier family 50 (sugar efflux transporter), member 1 1 155135344-155138857 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018095 Approved Expressed in all epididymis: 133.2 SLC51A OSTalpha ENSG00000163959 Solute carrier family 51, alpha subunit 3 196211487-196243178 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039123 Approved Tissue enhanced 0 duodenum: 30.1;liver: 35.2;small intestine: 72.7 colon: 10.2 SLC51B OSTbeta ENSG00000186198 Solute carrier family 51, beta subunit 15 65045370-65053396 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA008398, HPA008533 Supported Approved Vesicles
Mitochondria Tissue enhanced 0 duodenum: 87.8;small intestine: 120.6 cervix: 63.7 SLC52A1 FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1 ENSG00000132517 Solute carrier family 52 (riboflavin transporter), member 1 17 5032600-5052009 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011449 Uncertain Group enriched 10 duodenum: 37.1;placenta: 26.0;skin: 13.3;small intestine: 26.8 parathyroid gland: 2.6 SLC52A2 D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2 ENSG00000185803 Solute carrier family 52 (riboflavin transporter), member 2 8 144354135-144361272 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA063036 Approved Expressed in all placenta: 24.0 SLC52A3 bA371L19.1, C20orf54, hRFT2, RFVT3 ENSG00000101276 Solute carrier family 52 (riboflavin transporter), member 3 20 760080-776015 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049391 Approved Tissue enhanced 0 testis: 62.2 small intestine: 18.5 SLC5A1 D22S675, NAGT, SGLT1 ENSG00000100170 Solute carrier family 5 (sodium/glucose cotransporter), member 1 22 32043032-32113029 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015467, HPA051805, HPA055106 Supported Approved Nucleoplasm
Vesicles Group enriched 10 duodenum: 518.9;small intestine: 320.2 gallbladder: 40.3 SLC5A10 SGLT5 ENSG00000154025 Solute carrier family 5 (sodium/sugar cotransporter), member 10 17 18950345-19022595 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052014 Uncertain Tissue enriched 25 kidney: 43.7 bone marrow: 1.7 SLC5A12 MGC52019, SMCT2 ENSG00000148942 Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 11 26667019-26723427 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA060904 Supported Tissue enhanced 0 epididymis: 57.8;kidney: 172.6 small intestine: 34.0 SLC5A2 SGLT2 ENSG00000140675 Solute carrier family 5 (sodium/glucose cotransporter), member 2 16 31483002-31490860 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041603 Supported Tissue enriched 9 kidney: 25.3 testis: 2.8 SLC5A3 SMIT, SMIT1 ENSG00000198743 Solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 21 34073570-34106260 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA029791 Approved Plasma membrane
Cytosol Tissue enhanced 0 thyroid gland: 42.0 kidney: 32.9 SLC5A4 DJ90G24.4, SAAT1, SGLT3 ENSG00000100191 Solute carrier family 5 (glucose activated ion channel), member 4 22 32218476-32255341 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 9 duodenum: 18.5;small intestine: 21.8 lung: 2.3 SLC5A5 NIS ENSG00000105641 Solute carrier family 5 (sodium/iodide cotransporter), member 5 19 17871973-17895174 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB022364, HPA049055 Supported Tissue enhanced 0 salivary gland: 28.5;stomach: 56.7;thyroid gland: 20.6 cervix: 8.3 SLC5A6 SMVT ENSG00000138074 Solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 2 27199587-27212958 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036958 Approved Approved Cell Junctions Expressed in all epididymis: 82.1 SLC5A7 CHT1, hCHT ENSG00000115665 Solute carrier family 5 (sodium/choline cotransporter), member 7 2 107986523-108013994 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046105 Approved Nuclear bodies
Cell Junctions
Intermediate filaments Mixed thyroid gland: 2.0 SLC5A9 SGLT4 ENSG00000117834 Solute carrier family 5 (sodium/sugar cotransporter), member 9 1 48222685-48248644 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050263 Approved Actin filaments
Cytosol Group enriched 10 duodenum: 43.8;small intestine: 46.4 lung: 4.5 SLC6A1 GABATHG, GABATR, GAT1 ENSG00000157103 Solute carrier family 6 (neurotransmitter transporter), member 1 3 10992724-11039247 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013341, CAB022293 Supported Uncertain Mitochondria Group enriched 5 cerebral cortex: 119.7;liver: 50.3 parathyroid gland: 15.7 SLC6A11 GAT3 ENSG00000132164 Solute carrier family 6 (neurotransmitter transporter), member 11 3 10816200-10940733 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA037981 Supported Supported Tissue enhanced 0 cerebral cortex: 18.2;skin: 6.7 esophagus: 5.5 SLC6A12 BGT-1 ENSG00000111181 Solute carrier family 6 (neurotransmitter transporter), member 12 12 190077-214570 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034973, HPA057917 Approved Approved Golgi apparatus Tissue enhanced 0 kidney: 29.4;liver: 43.6 cerebral cortex: 14.8 SLC6A13 GAT2 ENSG00000010379 Solute carrier family 6 (neurotransmitter transporter), member 13 12 220621-262873 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036449, HPA052726 Approved Approved Mitochondria Tissue enriched 14 kidney: 152.9 fallopian tube: 11.2 SLC6A14 ENSG00000268104 Solute carrier family 6 (amino acid transporter), member 14 X 116436622-116461458 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003193 Uncertain Approved Vesicles Tissue enhanced 0 cervix, uterine: 11.0;lung: 23.9 breast: 9.2 SLC6A15 FLJ10316, hv7-3, NTT73, SBAT1, V7-3 ENSG00000072041 Solute carrier family 6 (neutral amino acid transporter), member 15 12 84859488-84913615 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008609 Uncertain Approved Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 23.1 placenta: 5.5 SLC6A16 NTT5 ENSG00000063127 Solute carrier family 6, member 16 19 49289638-49325225 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA076812 Approved Golgi apparatus Tissue enriched 18 testis: 161.8 lymph node: 9.0 SLC6A17 ENSG00000197106 Solute carrier family 6 (neutral amino acid transporter), member 17 1 110150486-110202202 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007663, HPA008044 Approved Approved Nucleus
Golgi apparatus Tissue enriched 10 cerebral cortex: 75.6 adrenal gland: 7.9 SLC6A18 FLJ31236, Xtrp2 ENSG00000164363 Solute carrier family 6 (neutral amino acid transporter), member 18 5 1225355-1246189 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA011885 Supported Tissue enriched 83 kidney: 8.2 epididymis: 0.0 SLC6A19 ENSG00000174358 Solute carrier family 6 (neutral amino acid transporter), member 19 5 1201595-1225117 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037415, HPA043207 Supported Group enriched 21 duodenum: 143.3;kidney: 91.3;small intestine: 160.0 rectum: 6.3 SLC6A2 NAT1, NET, NET1, SLC6A5 ENSG00000103546 Solute carrier family 6 (neurotransmitter transporter), member 2 16 55655604-55706192 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004057, CAB078195 Supported Supported Approved Mitochondria
Cytosol Tissue enhanced 0 adrenal gland: 29.4;placenta: 18.2;skin: 15.7 testis: 11.4 SLC6A20 XT3, Xtrp3 ENSG00000163817 Solute carrier family 6 (proline IMINO transporter), member 20 3 45755450-45796535 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029873 Approved Tissue enhanced 0 duodenum: 25.1;small intestine: 19.7 gallbladder: 10.9 SLC6A3 DAT, DAT1 ENSG00000142319 Solute carrier family 6 (neurotransmitter transporter), member 3 5 1392790-1445430 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level HPA013602, CAB016249, CAB078172 Uncertain Supported Approved Vesicles Not detected thyroid gland: 0.3 SLC6A4 5-HTT, HTT, OCD1, SERT1 ENSG00000108576 Solute carrier family 6 (neurotransmitter transporter), member 4 17 30194319-30236002 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054723, HPA074728 Supported Supported Golgi apparatus
Vesicles Group enriched 10 duodenum: 10.7;lung: 44.2;placenta: 26.3;small intestine: 46.2 esophagus: 3.1 SLC6A5 GLYT2, NET1 ENSG00000165970 Solute carrier family 6 (neurotransmitter transporter), member 5 11 20599400-20659285 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lung: 1.4 testis: 0.6 SLC6A6 TAUT ENSG00000131389 Solute carrier family 6 (neurotransmitter transporter), member 6 3 14402576-14489349 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015028, HPA016488 Supported Approved Cell Junctions
Cytosol Mixed ovary: 50.7 SLC6A7 PROT ENSG00000011083 Solute carrier family 6 (neurotransmitter transporter), member 7 5 150189957-150222788 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA028907 Uncertain Tissue enhanced 0 cerebral cortex: 17.0;rectum: 4.3 colon: 2.9 SLC6A8 CRTR, CT1 ENSG00000130821 Solute carrier family 6 (neurotransmitter transporter), member 8 X 153688099-153696593 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed small intestine: 90.8 SLC6A9 GLYT1 ENSG00000196517 Solute carrier family 6 (neurotransmitter transporter, glycine), member 9 1 43991500-44031467 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA013977 Uncertain Approved Nucleus
Golgi apparatus Tissue enhanced 0 skin: 49.8 adrenal gland: 31.0 SLC7A1 ATRC1, CAT-1, ERR, HCAT1, REC1L ENSG00000139514 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 13 29509410-29595688 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039721 Approved Mixed esophagus: 42.0 SLC7A10 asc-1 ENSG00000130876 Solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 19 33208664-33225850 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041884, HPA057036 Uncertain Uncertain Nucleus
Nucleoli Group enriched 23 adipose tissue: 31.5;cerebral cortex: 6.6 breast: 0.8 SLC7A11 xCT ENSG00000151012 Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 4 138164097-138242349 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064215 Approved Vesicles Tissue enhanced 0 cerebral cortex: 22.5 epididymis: 8.2 SLC7A13 AGT-1, XAT2 ENSG00000164893 Solute carrier family 7 (anionic amino acid transporter), member 13 8 86214052-86321146 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 102 kidney: 42.6 testis: 0.4 SLC7A14 KIAA1613, PPP1R142 ENSG00000013293 Solute carrier family 7, member 14 3 170459584-170586074 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045929 Approved Tissue enriched 8 cerebral cortex: 26.8 adrenal gland: 3.1 SLC7A2 ATRC2, CAT-2, HCAT2 ENSG00000003989 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 8 17497088-17570573 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009277 Supported Plasma membrane
Cell Junctions Tissue enhanced 0 parathyroid gland: 373.7 liver: 92.6 SLC7A3 ATRC3, CAT-3, FLJ14541 ENSG00000165349 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 X 70925582-70931125 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003629 Approved Tissue enhanced 0 endometrium: 7.8;prostate: 9.6;seminal vesicle: 7.4 smooth muscle: 4.0 SLC7A4 CAT-4, HCAT3, VH ENSG00000099960 Solute carrier family 7, member 4 22 21028718-21032840 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA031023 Approved Tissue enhanced 0 testis: 22.5 esophagus: 6.0 SLC7A5 CD98, D16S469E, E16, LAT1, MPE16 ENSG00000103257 Solute carrier family 7 (amino acid transporter light chain, L system), member 5 16 87830023-87869488 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052673, HPA056077 Approved Supported Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 90.5;testis: 84.4 bone marrow: 66.3 SLC7A6 KIAA0245, LAT-2, LAT3, y+LAT-2 ENSG00000103064 Solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 16 68264516-68301823 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050713 Uncertain Approved Vesicles
Plasma membrane Mixed adipose tissue: 35.1 SLC7A7 LPI, y+LAT-1 ENSG00000155465 Solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 14 22773222-22829820 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036227 Approved Tissue enhanced 0 kidney: 279.7 parathyroid gland: 159.0 SLC7A8 LAT2, LPI-PC1 ENSG00000092068 Solute carrier family 7 (amino acid transporter light chain, L system), member 8 14 23125295-23183674 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB046015, HPA051950, HPA060672 Supported Tissue enriched 8 parathyroid gland: 1066.4 kidney: 131.5 SLC7A9 CSNU3 ENSG00000021488 Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 19 32830509-32869766 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042591 Supported Group enriched 10 duodenum: 81.2;kidney: 69.6;small intestine: 125.7 liver: 8.9 SLC8A1 NCX1 ENSG00000183023 Solute carrier family 8 (sodium/calcium exchanger), member 1 2 40097270-40611053 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022694, HPA070007 Uncertain Supported Nucleoplasm
Plasma membrane Tissue enhanced 0 heart muscle: 79.5 seminal vesicle: 38.2 SLC8A2 KIAA1087, NCX2 ENSG00000118160 Solute carrier family 8 (sodium/calcium exchanger), member 2 19 47428017-47472168 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA050818, HPA054671 Supported Tissue enriched 11 cerebral cortex: 68.4 endometrium: 6.2 SLC8A3 NCX3 ENSG00000100678 Solute carrier family 8 (sodium/calcium exchanger), member 3 14 70044217-70189070 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 16.3;skeletal muscle: 6.1 adrenal gland: 1.7 SLC8B1 FLJ22233, NCKX6, NCLX, SLC24A6 ENSG00000089060 Solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 12 113298759-113359493 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA040668 Approved Expressed in all adrenal gland: 48.6 SLC9A1 APNH, NHE1, PPP1R143 ENSG00000090020 Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 1 27098815-27166981 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022371, HPA048532, HPA052891 Supported Supported Plasma membrane Expressed in all stomach: 66.4 SLC9A2 NHE2 ENSG00000115616 Solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 2 102619707-102711318 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA035121, HPA035122 Approved Approved Cell Junctions Tissue enhanced 0 colon: 20.9;rectum: 23.7;stomach: 25.8 testis: 10.6 SLC9A3 NHE3 ENSG00000066230 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 5 473310-524332 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036493, HPA036669 Supported Supported Plasma membrane Tissue enhanced 0 colon: 82.6;small intestine: 74.1 gallbladder: 66.3 SLC9A4 NHE4 ENSG00000180251 Solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 2 102473303-102533972 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036096 Approved Approved Nucleoplasm
Plasma membrane Tissue enriched 5 stomach: 51.1 kidney: 9.5 SLC9A5 NHE5 ENSG00000135740 Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 16 67237683-67272190 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA041004, HPA041329 Uncertain Approved Nucleoplasm
Cytosol Tissue enhanced 0 spleen: 7.8 cerebral cortex: 2.5 SLC9A6 KIAA0267, NHE6 ENSG00000198689 Solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 X 135985424-136047269 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059445, HPA059590 Approved Supported Vesicles Tissue enhanced 0 cerebral cortex: 76.1 parathyroid gland: 17.3 SLC9A7 NHE7 ENSG00000065923 Solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 X 46599252-46759172 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048938, HPA075385 Approved Supported Vesicles Mixed cerebral cortex: 14.4 SLC9A8 KIAA0939, NHE8 ENSG00000197818 Solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8 20 49812713-49892242 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB033682 Approved Expressed in all bone marrow: 13.2 SLC9A9 FLJ35613, NHE9 ENSG00000181804 Solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 3 143265222-143848531 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058234 Approved Mixed placenta: 22.1 SLC9B1 NHA1, NHEDC1 ENSG00000164037 Solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 4 102885048-103019739 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA035435, HPA058971, HPA065520 Uncertain Approved Mitochondria Tissue enriched 25 testis: 73.9 epididymis: 2.9 SLC9B2 FLJ23984, NHA2, NHEDC2 ENSG00000164038 Solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 4 103019868-103085829 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047008 Uncertain Approved Nucleoplasm
Cell Junctions Tissue enhanced 0 cerebral cortex: 32.6 liver: 20.5 SLC9C1 NHE, SLC9A10 ENSG00000172139 Solute carrier family 9, subfamily C (Na+-transporting carboxylic acid decarboxylase), member 1 3 112140887-112294258 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 9 skin: 2.9;testis: 14.1 thyroid gland: 0.9 SLC9C2 MGC43026, SLC9A11 ENSG00000162753 Solute carrier family 9, member C2 (putative) 1 173500464-173603094 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 12 testis: 10.6 fallopian tube: 0.8 SLCO1A2 OATP, OATP-A, OATP1A2, SLC21A3 ENSG00000084453 Solute carrier organic anion transporter family, member 1A2 12 21264600-21419594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA071152 Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 28.8 salivary gland: 6.6 SLCO1B1 LST-1, OATP-C, OATP1B1, SLC21A6 ENSG00000134538 Solute carrier organic anion transporter family, member 1B1 12 21131202-21239246 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050892 Supported Tissue enriched 249 liver: 307.4 breast: 1.2 SLCO1B3 OATP1B3, OATP8, SLC21A8 ENSG00000111700 Solute carrier organic anion transporter family, member 1B3 12 20810702-20916911 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004943, HPA050892 Supported Supported Plasma membrane Tissue enriched 7 liver: 138.5 cervix: 19.4 SLCO1C1 OATP-F, OATP1, OATP1C1, SLC21A14 ENSG00000139155 Solute carrier organic anion transporter family, member 1C1 12 20695355-20753386 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 10 cerebral cortex: 27.6 testis: 2.6 SLCO2A1 MATR1, OATP2A1, PGT, SLC21A2 ENSG00000174640 Solute carrier organic anion transporter family, member 2A1 3 133932696-134052184 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013742 Supported Tissue enhanced 0 seminal vesicle: 113.4 thyroid gland: 71.0 SLCO2B1 OATP-B, OATP2B1, SLC21A9 ENSG00000137491 Solute carrier organic anion transporter family, member 2B1 11 75100563-75206549 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020659 Uncertain Expressed in all liver: 123.0 SLCO3A1 OATP-D, OATP3A1, SLC21A11 ENSG00000176463 Solute carrier organic anion transporter family, member 3A1 15 91853695-92172435 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed parathyroid gland: 26.5 SLCO4A1 OATP-E, OATP4A1, SLC21A12 ENSG00000101187 Solute carrier organic anion transporter family, member 4A1 20 62642445-62685785 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030669, HPA030670 Uncertain Approved Cell Junctions Mixed esophagus: 10.6 SLCO4C1 OATP-H, OATP4C1, OATPX, SLC21A20 ENSG00000173930 Solute carrier organic anion transporter family, member 4C1 5 102233986-102296549 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 42.2 lung: 11.3 SLCO5A1 OATP-J, OATP5A1, OATPRP4, SLC21A15 ENSG00000137571 Solute carrier organic anion transporter family, member 5A1 8 69667047-69835064 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA025062 Uncertain Tissue enhanced 0 prostate: 3.6 skeletal muscle: 2.6 SLCO6A1 CT48, MGC26949, OATP6A1, OATPY ENSG00000205359 Solute carrier organic anion transporter family, member 6A1 5 102371782-102499016 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA054126 Supported Tissue enriched 136 testis: 53.7 placenta: 0.3 SPNS1 HSpin1, LAT, nrs, PP2030, SPIN1, SPINL ENSG00000169682 Spinster homolog 1 (Drosophila) 16 28974221-28984548 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041995, HPA042988 Supported Approved Nucleoli fibrillar center
Golgi apparatus
Vesicles
Cytosol Expressed in all parathyroid gland: 36.3 SPNS2 ENSG00000183018 Spinster homolog 2 (Drosophila) 17 4498838-4539035 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA068717 Uncertain Tissue enhanced 0 esophagus: 46.5 kidney: 29.9 STRA6 FLJ12541 ENSG00000137868 Stimulated by retinoic acid 6 15 74179466-74212267 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040839 Approved Approved Nucleus
Cytosol Tissue enhanced 0 cervix, uterine: 37.3;placenta: 20.4 endometrium: 13.5 TM4SF4 il-TMP ENSG00000169903 Transmembrane 4 L six family member 4 3 149473974-149503281 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046430 Supported Approved Plasma membrane
Cytosol Group enriched 34 duodenum: 595.8;gallbladder: 1326.5;liver: 343.7;small intestine: 515.2 stomach: 20.3 TMEM104 FLJ00021, FLJ20255 ENSG00000109066 Transmembrane protein 104 17 74776483-74839779 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044330 Approved Approved Nucleoplasm
Golgi apparatus Expressed in all parathyroid gland: 14.7 TMEM163 DKFZP566N034, SV31 ENSG00000152128 Transmembrane protein 163 2 134455759-134719000 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA007224 Uncertain Mixed lung: 21.5 TMEM165 GDT1, TMPT27, TPARL ENSG00000134851 Transmembrane protein 165 4 55395957-55453397 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038299 Supported Supported Golgi apparatus
Vesicles Expressed in all placenta: 86.4 TMEM180 bA18I14.8, C10orf77, FLJ22529 ENSG00000138111 Transmembrane protein 180 10 102461395-102477045 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA018031 Uncertain Approved Golgi apparatus
Cytosol Mixed skin: 8.8 TMEM184B C22orf5, DKFZP586A1024, FM08, HS5O6A ENSG00000198792 Transmembrane protein 184B 22 38219291-38273034 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024076 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Expressed in all cerebral cortex: 57.5 TMEM234 C1orf91, dJ622L5.7, FLJ90779, RP4-622L5 ENSG00000160055 Transmembrane protein 234 1 32214472-32222359 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015049 Uncertain Approved Vesicles Mixed epididymis: 12.8 TMEM27 NX17 ENSG00000147003 Transmembrane protein 27 X 15627318-15665031 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048543 Approved Approved Endoplasmic reticulum
Vesicles Tissue enriched 16 kidney: 418.5 parathyroid gland: 26.1 UCP1 SLC25A7, UCP ENSG00000109424 Uncoupling protein 1 (mitochondrial, proton carrier) 4 140559434-140568805 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 3.7 breast: 0.9 UCP2 BMIQ4, SLC25A8 ENSG00000175567 Uncoupling protein 2 (mitochondrial, proton carrier) 11 73974667-73983307 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB025583 Approved Expressed in all lymph node: 391.2 UCP3 SLC25A9 ENSG00000175564 Uncoupling protein 3 (mitochondrial, proton carrier) 11 74000281-74009435 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB010771, HPA072225 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 19 skeletal muscle: 71.2 testis: 3.8 XK Kx, NA, NAC, X1k, XKR1 ENSG00000047597 X-linked Kx blood group X 37685759-37732130 Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019036 Approved Approved Nucleoplasm
Vesicles
Mitochondria Mixed rectum: 12.3 XKR3 MGC57211, XTES ENSG00000172967 XK, Kell blood group complex subunit-related family, member 3 22 16783412-16821699 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003379, HPA035081 Uncertain Tissue enriched 80 testis: 14.3 cerebral cortex: 0.1 XKR4 KIAA1889 ENSG00000206579 XK, Kell blood group complex subunit-related family, member 4 8 55102389-55542054 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA025072, HPA028083 Uncertain Tissue enriched 6 cerebral cortex: 4.7 seminal vesicle: 0.8 XKR8 FLJ10307 ENSG00000158156 XK, Kell blood group complex subunit-related family, member 8 1 27959462-27968096 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA049984, HPA053529 Uncertain Approved Golgi apparatus Expressed in all placenta: 13.6 XKR9 ENSG00000221947 XK, Kell blood group complex subunit-related family, member 9 8 70669365-70790371 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044430 Uncertain Approved Mitochondria Tissue enhanced 0 testis: 14.1 small intestine: 6.2 XKRX XKR2, XPLAC ENSG00000182489 XK, Kell blood group complex subunit-related, X-linked X 100913445-100929433 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 skin: 9.5 tonsil: 3.3